Sumitomo Pharma Co. Ltd (SMDPY PINK) stock market data APIs
$10.4134
0(0%)
as of September 11, 2026
Try our APIs with
free plan!
Sumitomo Pharma Co. Ltd Financial Data Overview
Price chart is built with
Anychart
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Prev. Close
10.4134
Open
10.4134
High
10.4134
Low
10.4134
52 wk Range
7.84-24.48
Market Cap
4 688 M
P/E Ratio
5.9714
Shares Outstanding
449 M
Revenue
474 787 M
EPS
0.2448
Beta
0.48
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sumitomo Pharma Co. Ltd data using free add-ons & libraries
Get Sumitomo Pharma Co. Ltd Fundamental Data
Sumitomo Pharma Co. Ltd Fundamental data includes:
- Net Revenue: 474 787 M
- EBITDA: 68 338 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sumitomo Pharma Co. Ltd News
New
2026 Assessment of the Nuvisertib Market: Sales Forecasts, Clinical Differentiation, Competitive Threats, and Commercial Opportunities Through 2034
Company Logo Nuvisertib targets unmet needs in relapsed/refractory myelofibrosis with differentiated, potentially disease-modifying activity. Combination therapy, expansion into other cancers and exp...
Sumitomo Pharma (TSE:4506) Stock Looks Below Fair Value On Earnings Power
Sumitomo Pharma stock has delivered a very large 3 year gain but the broader valuation checks still suggest the shares trade on the cheap side compared with the fundamentals. After a weak year to date...
Interest Rate, Oil, Tech Jitters Blunt Asian Stock Markets
Asian stock markets fell back Wednesday on overnight Wall Street cues, and as traders cooled on tech PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa
– DSP-3077 is an investigational allogeneic iPS cell-derived retinal sheet (3-dimensional [3D] retina) that is administered via subretinal injection – – The Phase 1/2a study is evaluating safet...
Get Sumitomo Pharma Co. Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
